Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Open in API
Filings indexed 940 across all filing types
Latest filing 2023-10-23 Regulatory Filings
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a press release attached as Exhibit 99.1 dated October 20, 2023. The document is short (2081 characters) and primarily serves to furnish information rather than provide detailed financial data or comprehensive reports. It explicitly states that the attached press release is being furnished and not filed, indicating this is an announcement-type filing. There is no substantive financial data or detailed report content within the text itself. According to the rules, such filings that are brief and serve to announce or furnish information without detailed financial statements or analysis fall under Regulatory Filings (RNS).
2023-10-23 English
MDxHealth - Press Release (ENG).pdf
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces an increase in the company's share capital and the total number of issued and outstanding shares following a capital increase completed on October 20, 2023. It details the change in capital amount and the issuance of 2,500,000 new shares. This content directly relates to changes in the company's capital structure and share count, matching the definition for 'Share Issue/Capital Change' (SHA). Although it involves financing (CAP), the primary focus is the resulting change in the share count, making SHA the most precise fit.
2023-10-20 English
MDxHealth - Press Release (FR).pdf
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated October 20, 2023, titled "Nouveau montant du capital et nouveau nombre d'actions de Mdxhealth" (New capital amount and new number of shares of Mdxhealth). It explicitly states that due to a capital increase, the company's capital and the number of issued and outstanding shares have changed (from 270,380,936 to 272,880,936 shares). This directly relates to changes in the company's capital structure, including the issuance of new shares and details about outstanding warrants and debt conversion rights. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV).
2023-10-20 French
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes information about an Extraordinary General Shareholders' Meeting, specifically a proxy card and a notice from the depositary about the meeting. The document is relatively short (2469 characters) and does not contain financial statements or detailed financial analysis. It primarily serves as a regulatory filing to inform about the meeting and related materials. According to the rules, such filings that do not fit other categories and are regulatory announcements fall under Regulatory Filings (RNS).
2023-10-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release attached as Exhibit 99.1 but does not contain detailed financial statements or substantive financial data itself. The document length is 2069 characters, which is relatively short and consistent with a regulatory filing or announcement rather than a full report. The text explicitly states that the attached press release is being furnished and not filed, indicating this document serves as a regulatory filing to inform the SEC and investors of recent events or disclosures. According to the classification rules, Form 6-K filings are best categorized under Regulatory Filings (RNS) as they are miscellaneous regulatory announcements that do not fit other specific categories like Annual Report or Interim Report. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2023-10-10 English
PR 2023 10 09 EN.pdf
Earnings Release Classification · 100% confidence The document is explicitly titled "NEWS RELEASE" and begins by stating it reports "Preliminary Q3-2023 Revenues." It provides key financial metrics (revenues, test volumes, cash position) for the third quarter, which is characteristic of an Earnings Release (ER). The text also mentions that the company is scheduled to release its *full* third quarter results on a later date (November 8, 2023), confirming this document is the preliminary announcement, not the comprehensive report (IR) or the full transcript (CT). The length (7634 chars) is substantial but the content is focused on preliminary results announcement, fitting the ER definition. Q3 2023
2023-10-09 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.